Bristol-Myers Squibb Company
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionGrimes & Company, Inc.
Latest Disclosed Ownership371,095 shares
Latest Disclosed Value $ 22,506,895
Grimes & Company, Inc. reports 6.75% increase in ownership of BMY / Bristol-Myers Squibb Company

On April 21, 2026 - Grimes & Company, Inc. filed a 13F-HR form disclosing ownership of 371,095 shares of Bristol-Myers Squibb Company (US:BMY) valued at $22,506,912 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 347,619 shares of Bristol-Myers Squibb Company. This represents a change in shares of 6.75% during the quarter. The current value of the position is $20,306,318 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 371,095 23,476 6.75 22,507 20.03 0.5177
2026-02-03 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 347,619 -28,024 -7.46 18,751 10.68 0.4480
2025-10-27 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 375,643 -22,215 -5.58 16,942 -8.01 0.4183
2025-07-22 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 397,858 -24,916 -5.89 18,417 -28.58 0.5012
2025-04-17 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 422,774 -13,227 -3.03 25,785 4.56 0.7971
2025-01-21 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 436,001 -9,507 -2.13 24,660 6.98 0.7105
2024-10-22 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 445,508 846 0.19 23,051 24.82 0.6238
2024-07-22 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 444,662 64,021 16.82 18,467 -10.54 0.5527
2024-04-17 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 380,641 35,677 10.34 20,642 16.62 0.6346
2024-01-24 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 344,964 13,524 4.08 17,700 -7.99 0.5860
2023-10-19 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 331,440 14,084 4.44 19,237 -5.21 0.7439
2023-07-19 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 317,356 7,491 2.42 20,295 -5.50 0.7196
2023-04-20 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 309,865 11,672 3.91 21,477 0.10 0.8801
2023-01-25 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 298,193 2,729 0.92 21,455 2.14 0.9057
2022-10-28 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 295,464 4,778 1.64 21,005 -6.16 1.0962
2022-07-22 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 290,686 1,984 0.69 22,383 6.16 1.1286
2022-05-06 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 288,702 94,069 48.33 21,084 73.75 0.9849
2022-02-01 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 194,633 3,005 1.57 12,135 7.02 0.5555
2021-11-08 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 191,628 8,079 4.40 11,339 -7.55 0.4934
2021-08-04 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 183,549 3,822 2.13 12,265 8.10 0.5322
2021-05-12 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 179,727 22,711 14.46 11,346 16.49 0.5456
2021-02-02 2020-12-31 13F Bristol Myers Squibb COM 110122108 157,016 1,828 1.18 9,740 4.10 0.5060
2020-11-12 2020-09-30 13F Bristol Myers Squibb COM 110122108 155,188 -4,525 -2.83 9,356 -0.37 0.5984
2020-07-31 2020-06-30 13F Bristol Myers Squibb COM 110122108 159,713 -3,264 -2.00 9,391 3.38 0.6525
2020-05-05 2020-03-31 13F Bristol Myers Squibb COM 110122108 162,977 -3,400 -2.04 9,084 -14.94 0.8291
2020-02-05 2019-12-31 13F Bristol Myers Squibb COM 110122108 166,377 -8,197 -4.70 10,680 20.64 0.6997
2019-11-05 2019-09-30 13F Bristol Myers Squibb COM 110122108 174,574 2,661 1.55 8,853 13.56 0.6307
2019-07-30 2019-06-30 13F Bristol Myers Squibb COM 110122108 171,913 6,304 3.81 7,796 -1.33 0.5916
2019-05-02 2019-03-31 13F Bristol Myers Squibb COM 110122108 165,609 157,818 2,025.64 7,901 1,850.86 0.6193
2019-02-01 2018-12-31 13F Bristol Myers Squibb COM 110122108 7,791 5 0.06 405 -16.15 0.0395
2018-11-09 2018-09-30 13F Bristol Myers Squibb COM 110122108 7,786 -397 -4.85 483 6.62 0.0387
2018-08-10 2018-06-30 13F Bristol Myers Squibb COM 110122108 8,183 -1,521 -15.67 453 -26.22 0.0400
2018-05-07 2018-03-31 13F Bristol Myers Squibb COM 110122108 9,704 1,579 19.43 614 23.29 0.0595
2018-02-05 2017-12-31 13F Bristol Myers Squibb COM 110122108 8,125 14 0.17 498 -3.68 0.0481
2017-11-03 2017-09-30 13F Bristol Myers Squibb COM 110122108 8,111 5 0.06 517 14.38 0.0550
2017-07-18 2017-06-30 13F Bristol Myers Squibb COM 110122108 8,106 5 0.06 452 2.49 0.0504
2017-05-01 2017-03-31 13F Bristol Myers Squibb COM 110122108 8,101 -275 -3.28 441 -10.00 0.0483
2017-01-24 2016-12-31 13F Bristol Myers Squibb COM 110122108 8,376 -145 -1.70 490 6.75 0.0568
2016-10-24 2016-09-30 13F Bristol Myers Squibb COM 110122108 8,521 404 4.98 459 -23.12 0.0614
2016-07-25 2016-06-30 13F Bristol Myers Squibb COM 110122108 8,117 -135 -1.64 597 13.28 0.0798
2016-04-25 2016-03-31 13F Bristol Myers Squibb COM 110122108 8,252 4 0.05 527 -7.05 0.0678
2016-02-03 2015-12-31 13F Bristol Myers Squibb COM 110122108 8,248 4 0.05 567 16.19 0.0766
2015-10-08 2015-09-30 13F Bristol Myers Squibb COM 110122108 8,244 -117 -1.40 488 -12.23 0.0628
2015-08-11 2015-06-30 13F Bristol Myers Squibb COM 110122108 8,361 -197 -2.30 556 0.72 0.0783
2015-04-24 2015-03-31 13F Bristol Myers Squibb COM 110122108 8,558 318 3.86 552 13.58 0.1327
2015-02-12 2014-12-31 13F Bristol Myers Squibb COM 110122108 8,240 4 0.05 486 15.17 0.1256
2014-11-06 2014-09-30 13F Bristol Myers Squibb COM 110122108 8,236 662 8.74 422 14.99 0.1104
2014-07-28 2014-06-30 13F Bristol Myers Squibb COM 110122108 7,574 127 1.71 367 -5.17 0.0962
2014-05-01 2014-03-31 13F Bristol Myers Squibb COM 110122108 7,447 1,900 34.25 387 31.19 0.1087
2014-02-03 2013-12-31 13F Bristol Myers Squibb COM 110122108 5,547 5,547 295 0.0882
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.